-
1.
公开(公告)号:US20230257741A1
公开(公告)日:2023-08-17
申请号:US17759402
申请日:2021-01-29
IPC分类号: C12N15/113 , A61K31/7115 , A61P35/00
CPC分类号: C12N15/113 , A61K31/7115 , A61P35/00
摘要: The inventive technology relates to systems and methods for the use of chemically modified antisense oligonucleotides (ASOs) to sterically prevent intron excision thus causing nuclear retention of the RNA and inhibiting nuclear export. In preferred therapeutic embodiments, ASOs may be engineered to quarantine clinically relevant RNAs in the nucleus of the cell.